CGA PS-44 (R2022) PDF

Description

CGA PS-44 (R2022) – CGA Position Statement on Designated Medical Gases are Not Active Pharmaceutical Ingredients

This position statement answers the question: Are designated medical gases ever considered active pharmaceutical ingredients (API) by the U.S. Food and Drug Administration (FDA).

Product Details

Edition:

1st

Published:

02/29/2016

Number of Pages:

2

File Size:

1 file , 130 KB

Note:

This product is unavailable in Russia, Ukraine, Belarus